C-POST protocol update: A Phase 3, randomized, double-blind study of adjuvant cemiplimab versus placebo post surgery and radiation therapy in patients with high-risk cutaneous squamous cell carcinoma. J of Skin [Internet]. 2023 Mar. 13 [cited 2025 Apr. 19];7(2):s173. Available from: https://skin.dermsquared.com/skin/article/view/1996